A detailed history of Aviva PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aviva PLC holds 1,213,033 shares of ABT stock, worth $142 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,213,033
Previous 1,171,426 3.55%
Holding current value
$142 Million
Previous $122 Million 13.62%
% of portfolio
0.38%
Previous 0.36%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $4.16 Million - $4.92 Million
41,607 Added 3.55%
1,213,033 $138 Million
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $15.6 Million - $17.5 Million
155,319 Added 15.29%
1,171,426 $122 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $4.19 Million - $4.63 Million
38,244 Added 3.91%
1,016,107 $115 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $4.29 Million - $5.25 Million
47,591 Added 5.12%
977,863 $108 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $17.1 Million - $20.5 Million
179,041 Added 23.83%
930,272 $90.1 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $41.7 Million - $46.4 Million
413,453 Added 122.4%
751,231 $81.9 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $10.2 Million - $12 Million
-104,972 Reduced 23.71%
337,778 $34.2 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $4.77 Million - $5.59 Million
50,137 Added 12.77%
442,750 $48.6 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $3.15 Million - $3.65 Million
-32,543 Reduced 7.65%
392,613 $38 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $8.07 Million - $9.75 Million
-79,064 Reduced 15.68%
425,156 $46.2 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $31.2 Million - $38.1 Million
-273,703 Reduced 35.18%
504,220 $59.7 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $7.37 Million - $9.02 Million
-63,784 Reduced 7.58%
777,923 $109 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $9.25 Million - $10.2 Million
-79,293 Reduced 8.61%
841,707 $99.4 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $340,009 - $400,239
-3,214 Reduced 0.35%
921,000 $107 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $37.4 Million - $44 Million
343,210 Added 59.07%
924,214 $111 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $1.92 Million - $2.1 Million
18,319 Added 3.26%
581,004 $63.6 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $6.2 Million - $7.53 Million
-67,633 Reduced 10.73%
562,685 $61.2 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $1.77 Million - $2.26 Million
-23,064 Reduced 3.53%
630,318 $57.6 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $19 Million - $27.8 Million
-302,410 Reduced 31.64%
653,382 $51.6 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $11 Million - $12.3 Million
-140,663 Reduced 12.83%
955,792 $83 Million
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $1.38 Million - $1.5 Million
-16,853 Reduced 1.51%
1,096,455 $91.7 Million
Q2 2019

Jul 30, 2019

SELL
$72.88 - $85.0 $8.63 Million - $10.1 Million
-118,347 Reduced 9.61%
1,113,308 $93.6 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $123,500 - $149,311
1,865 Added 0.15%
1,231,655 $98.5 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $1.15 Million - $1.3 Million
-17,571 Reduced 1.41%
1,229,790 $89 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $2.41 Million - $2.91 Million
39,665 Added 3.28%
1,247,361 $91.5 Million
Q2 2018

Aug 01, 2018

BUY
$57.57 - $63.54 $20 Million - $22 Million
346,717 Added 40.27%
1,207,696 $73.7 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $4.53 Million - $5.12 Million
-80,476 Reduced 8.55%
860,979 $51.6 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $7.4 Million - $7.92 Million
-137,886 Reduced 12.78%
941,455 $53.7 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $457,050 - $510,116
9,510 Added 0.89%
1,079,341 $57.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
1,069,831
1,069,831 $52 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.